At LenioBio, we believe every person should have the opportunity to live a healthy and productive life. And how do we do this? We develop robust, efficient and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are.
We are in the midst of an incredible journey and we are looking for passionate individuals to join us on this important mission. Do you want to be part of our journey? Then please keep reading!
At LenioBio GmbH, everything we do begins with our mission: to provide our customers with disruptive solutions to address their challenges easier, quicker, cheaper, better and safer.
Our ALiCE technology scales with the pharmaceutical R&D process, from discovery to clinical trials/product testing and finally, to GMP-grade production, in the form of an end-to-end integrated production platform.
LenioBio aims to unlock the full potential of ALiCE and will enable protein drugs to be brought to market faster and at a lower cost.
About this job
We are looking for a senior scientist to help us better understand the ALiCE system at the molecular level. You will be our expert in understanding the protein glycosylation and molecular details of related post-translational modifications occurring in the proteins produced in ALiCE. You will also help us design experiments to engineer the glycan structures on cell-free produced proteins to make the proteins therapeutically more active as well as more acceptable for the regulatory agencies.
We are looking for people that want to bring in their best, learn from the best, and create the best. That does not mean you scored 180 on an IQ test. It means that you are an expert in your craft because you love what you do, you know you can become even better, and you are constantly looking for the boundary of the possible.
This job will suit you best if you
What we offer
Who we are
LenioBio is a biotech company that develops and markets a novel and proprietary protein production platform, ALiCE®, which enables protein-based therapeutics to become more accessible and affordable. LenioBio was founded in 2016 in Germany to broadly commercialize the ALiCE® platform, originally developed by DowDuPont and the Fraunhofer Institute IME.
In August 2019, LenioBio closed its Series A investment round with private investors and won a grant from the European Commission under the Horizon 2020 program/SME-2.
Why you should join us
Everyone is welcome - as an inclusive workplace, our employees are comfortable bringing their whole authentic selves to work, where everyone feels safe, valued, and they belong.
Be you. We like it that way.
At LenioBio, we succeed together, and you will be part of a global family where you can use your creativity and enjoy a fun working environment, where you can make a difference and craft your own career.
That’s why you own your projects and take full responsibility from day one. Our growing business worldwide open up countless opportunities to follow your convictions and explore new paths.
If you have an entrepreneurial mindset that allows you to always think out of the box - take the chance and shape the future together with us. You will be joining a team of driven entrepreneurs. We will not give up until we make a huge dent in this industry!